Here's how many Texas jobs are at risk of being replaced by AI — according to AI

the tech is coming

AI and automation are coming for Texas jobs, according to ChatGPT. Image via Getty Images

ChatGPT seems to have its eyes set on at least 200,000 Texas jobs, according to a new study.

The report by UK-based affiliate marketing site NetVoucherCodes compiled data on nearly 200 U.S. job types and then asked ChatGPT for each job’s relative risk from AI, automation, and also the likelihood of AI increasing that job’s productivity.

The query found that 237,000 jobs in Texas have a high risk of being replaced by AI, and 1.07 million jobs are considered at a medium risk of being replaced by AI.

Similarly 1.8 million Texas jobs were considered at a high risk of being replaced by automation. More than 3 million jobs were considered at a medium risk of being replaced by automation.

In both the AI and automation queries, Texas had the second-most at risk jobs among the states. California had the most jobs at risk in both categories. New York fell behind Texas in the No. 3 spot for most jobs being at risk of being replaced by AI, and Florida had the third most jobs at risk of being replaced by automation.

Maine had the highest number of low-risk jobs, followed by Hawaii and Montana.

Texas jobs that were both at high risk and made up a large portion of Texas's workforce include fast food and counter workers, cashiers, customer service representatives, and stockers and order fillers.

“The data we’ve pulled together shows that a lot of lower income jobs are the ones that are at a higher risk of being replaced. When we break this down, we realize it’s because these jobs often involve a lot of the same repetitive tasks. This can be inputted into a computer and can be done automatically," John Strizaker from NetVoucherCodes said in a statement.

“The jobs that aren’t at risk are ones that really require human thinking and decision making, like nurses, doctors along with creative roles such as fashion designers and hairdressers," he continued.

At the same time, the study found that more than 1.4 million Texas jobs have a high likelihood of being able to use AI and automation to boost productivity. This was the second highest number of jobs in this category behind California.

“Although this might be a concern in the near future, there’s a lot of benefits to AI and automation," Strizaker said in the statement. "It will increase productivity, especially in creative fields and it will be able to take over repetitive tasks and free up workers for other things that require thinking.”

Some Houston companies are already using GPT, or generative pre-trained transformer, technology to their advantage. Femtech company ema pivoted to use the powerful tool to provide access to women's health information 24/7 to its users about 16 months ago.

And at the start of this year the University of Houston and Intel launched a new artificial intelligence program to help bridge the AI knowledge gap and fill hundreds of AI-related jobs that are open in the Houston area.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Texas space co. takes giant step toward lunar excavator deployment

Out of this world

Lunar exploration and development are currently hampered by the fact that the moon is largely devoid of necessary infrastructure, like spaceports. Such amenities need to be constructed remotely by autonomous vehicles, and making effective devices that can survive the harsh lunar surface long enough to complete construction projects is daunting.

Enter San Antonio-based Astroport Space Technologies. Founded in San Antonio in 2020, the company has become a major part of building plans beyond Earth, via its prototype excavator, and in early February, it completed an important field test of its new lunar excavator.

The new excavator is designed to function with California-based Astrolab's Flexible Logistics and Exploration (FLEX) rover, a highly modular vehicle that will perform a variety of functions on the surface of the moon.

In a recent demo, the Astroport prototype excavator successfully integrated with FLEX and proceeded to dig in a simulated lunar surface. The excavator collected an average of 207 lbs (94kg) of regolith (lunar surface dust) in just 3.5 minutes. It will need that speed to move the estimated 3,723 tons (3,378 tonnes) of regolith needed for a lunar spaceport.

After the successful test, both Astroport and Astrolab expressed confidence that the excavator was ready for deployment. "Leading with this successful excavator demo proves that our technology is no longer theoretical—it is operational," said Sam Ximenes, CEO of Astroport.

"This is the first of many implements in development that will turn Astrolab's FLEX rover into the 'Swiss Army Knife' of lunar construction. To meet the infrastructure needs of the emerging lunar economy, we must build the 'Port' before the 'Ship' arrives. By leveraging the FLEX platform, we are providing the Space Force, NASA, and commercial partners with a 'Shovel-Ready' construction capability to secure the lunar high ground."

"We are excited to provide the mobility backbone for Astroport's groundbreaking construction technology," said Jaret Matthews, CEO of Astrolab, in a release. "Astrolab is dedicated to establishing a viable lunar ecosystem. By combining our FLEX rover's versatility with Astroport's civil engineering expertise, we are delivering the essential capabilities required for a sustainable lunar economy."

---

This article originally appeared on CultureMap.com.

Houston biotech co. raises $11M to advance ALS drug development

drug money

Houston-based clinical-stage biotechnology company Coya Therapeutics (NASDAQ: COYA) has raised $11.1 million in a private investment round.

India-based pharmaceuticals company Dr. Reddy’s Laboratories Inc. led the round with a $10 million investment, according to a news release. New York-based investment firm Greenlight Capital, Coya’s largest institutional shareholder, contributed $1.1 million.

The funding was raised through a definitive securities purchase agreement for the purchase and sale of more than 2.5 million shares of Coya's common stock in a private placement at $4.40 per share.

Coya reports that it plans to use the proceeds to scale up manufacturing of low-dose interleukin-2 (IL-2), which is a component of its COYA 302 and will support the commercial readiness of the drug. COYA 302 enhances anti-inflammatory T cell function and suppresses harmful immune activity for treatment of Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), Parkinson’s disease and Alzheimer’s disease.

The company received FDA acceptance for its investigational new drug application for COYA 302 for treating ALS and FTD this summer. Its ALSTARS Phase 2 clinical trial for ALS treatment launched this fall in the U.S. and Canada and has begun enrolling and dosing patients. Coya CEO Arun Swaminathan said in a letter to investors that the company also plans to advance its clinical programs for the drug for FTD therapy in 2026.

Coya was founded in 2021. The company merged with Nicoya Health Inc. in 2020 and raised $10 million in its series A the same year. It closed its IPO in January 2023 for more than $15 million. Its therapeutics uses innovative work from Houston Methodist's Dr. Stanley H. Appel.

New accelerator for AI startups to launch at Houston's Ion this spring

The Collectiv Foundation and Rice University have established a sports, health and wellness startup accelerator at the Ion District’s Collectiv, a sports-focused venture capital platform.

The AI Native Dual-Use Sports, Health & Wellness Accelerator, scheduled to formally launch in March, will back early-stage startups developing AI for the sports, health and wellness markets. Accelerator participants will gain access to a host of opportunities with:

  • Mentors
  • Advisers
  • Pro sports teams and leagues
  • University athletics programs
  • Health care systems
  • Corporate partners
  • VC firms
  • Pilot projects
  • University-based entrepreneurship and business initiatives

Accelerator participants will focus on sports tech verticals inlcuding performance and health, fan experience and media platforms, data and analytics, and infrastructure.

“Houston is quickly becoming one of the most important innovation hubs at the intersection of sports, health, and AI,” Ashley DeWalt, co-founder and managing partner of The Collectiv and founder of The Collectiv Foundation, said in a news release.

“By launching this platform with Rice University in the Ion District,” he added, “we are building a category-defining acceleration engine that gives founders access to world-class research, global sports properties, hospital systems, and venture capital. This is about turning sports-validated technology into globally scalable companies at a moment when the world’s attention is converging on Houston ahead of the 2026 World Cup.”

The Collectiv accelerator will draw on expertise from organizations such as the Rice-Houston Methodist Center for Human Performance, Rice Brain Institute, Rice Gateway Project and the Texas Medical Center.

“The combination of Rice University’s research leadership, Houston’s unmatched health ecosystem, and The Collectiv’s operator-driven investment platform creates a powerful acceleration engine,” Blair Garrou, co-founder and managing partner of the Mercury Fund VC firm and a senior adviser for The Collectiv, added in the release.

Additional details on programming, partners and application timelines are expected to be announced in the coming weeks.

View All Listings